Blue Rock Advisors’s Sanofi SNY Stock Holding History

Blue Rock Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,174	Closed	-$59K	–	80
2020 Q3	$59K	Buy	+1,174	New	+$60.4K	0.05%	84

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Rock Advisors's SNY Position: Q4 2020 in Review

Blue Rock Advisors sold out of Sanofi (SNY) in Q4 2020, closing a stake of 1,174 shares — an estimated $59K sold.

Blue Rock Advisors first reported a position in SNY in Q3 2020 and held it in 1 quarter. The position peaked at $59K in Q3 2020. 602 funds tracked by Wall St. Rank hold SNY as of Q4 2020.

Blue Rock Advisors reported no remaining Sanofi position as of Q4 2020 after selling out during the quarter.
Blue Rock Advisors sold 1,174 Sanofi shares in Q4 2020, an estimated $59K.
Blue Rock Advisors first reported a position in Sanofi in Q3 2020 and held it in 1 quarter.
Blue Rock Advisors's Sanofi position peaked at $59K in Q3 2020.
602 funds tracked by Wall St. Rank held Sanofi as of Q4 2020.

Based on Blue Rock Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.